Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by longterm56on Jul 20, 2018 7:18pm
234 Views
Post# 28347415

RE:Information

RE:Information
Bucknelly21 wrote: I’m not much for these sites but I thought I would take a look at what people are saying and how much they think they know about th. If you guys had half of the info I have on this company no one other than day traders would sell. Anyone that thinks that this stock will go and stay down is severely misinformed. If you all are serious you would buy as much as you can at these levels. FYI Bloomberg’s numbers are so far off right now it’s a joke, furthermore there is not one competent analyst reporting on this stock. Early August a report will come out decribing the true numbers and value of this company.



Yea, you're going to have to do better than that on this board ... many of us have been following TH for years and can discern information consistent with what we know versus straight BS. 

When you want to convince us that you have "half of the info I have" ... then let us know and we can filter it through what we already know is true. Anything less will be ignored. 

  -LT

Bullboard Posts